Sensing the oxygen and temperature in the adipose tissues – who’s sensing what?
2
조회
0
다운로드
2
인용
0
참고문헌
초록
Adipose tissues, composed of various cell types, including adipocytes, endothelial cells, neurons, and immune cells, are organs that are exposed to dynamic environmental challenges. During diet-induced obesity, white adipose tissues experience hypoxia due to adipocyte hypertrophy and dysfunctional vasculature. Under these conditions, cells in white adipose tissues activate hypoxia-inducible factor (HIF), a transcription factor that activates signaling pathways involved in metabolism, angiogenesis, and survival/apoptosis to adapt to such an environment. Exposure to cold or activation of the β-adrenergic receptor (through catecholamines or chemicals) leads to heat generation, mainly in brown adipose tissues through activating uncoupling protein 1 (UCP1), a proton uncoupler in the inner membrane of the mitochondria. White adipose tissues can undergo a similar process under this condition, a phenomenon known as ‘browning’ of white adipose tissues or ‘beige adipocytes’. While UCP1 expression has largely been confined to adipocytes, HIF can be expressed in many types of cells. To dissect the role of HIF in specific types of cells during diet-induced obesity, researchers have generated tissue-specific knockout (KO) mice targeting HIF pathways, and many studies have commonly revealed that intact HIF-1 signaling in adipocytes and adipose tissue macrophages exacerbates tissue inflammation and insulin resistance. In this review, we highlight some of the key findings obtained from these transgenic mice, including Ucp1 KO mice and other models targeting the HIF pathway in adipocytes, macrophages, or endothelial cells, to decipher their roles in diet-induced obesity.
Abstract
Adipose tissues, composed of various cell types, including adipocytes, endothelial cells, neurons, and immune cells, are organs that are exposed to dynamic environmental challenges. During diet-induced obesity, white adipose tissues experience hypoxia due to adipocyte hypertrophy and dysfunctional vasculature. Under these conditions, cells in white adipose tissues activate hypoxia-inducible factor (HIF), a transcription factor that activates signaling pathways involved in metabolism, angiogenesis, and survival/apoptosis to adapt to such an environment. Exposure to cold or activation of the β-adrenergic receptor (through catecholamines or chemicals) leads to heat generation, mainly in brown adipose tissues through activating uncoupling protein 1 (UCP1), a proton uncoupler in the inner membrane of the mitochondria. White adipose tissues can undergo a similar process under this condition, a phenomenon known as ‘browning’ of white adipose tissues or ‘beige adipocytes’. While UCP1 expression has largely been confined to adipocytes, HIF can be expressed in many types of cells. To dissect the role of HIF in specific types of cells during diet-induced obesity, researchers have generated tissue-specific knockout (KO) mice targeting HIF pathways, and many studies have commonly revealed that intact HIF-1 signaling in adipocytes and adipose tissue macrophages exacerbates tissue inflammation and insulin resistance. In this review, we highlight some of the key findings obtained from these transgenic mice, including Ucp1 KO mice and other models targeting the HIF pathway in adipocytes, macrophages, or endothelial cells, to decipher their roles in diet-induced obesity.
참고문헌 (93)
- Blüher, M., "Obesity : global epidemiology and pathogenesis", Nat. Rev. Endocrinol, 15, pp.288~298 (2019)
- Bray, G., "Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation", Obes. Rev, 18, pp.715~723 (2017)
- Trayhurn, P., "Hypoxia and adipose tissue function and dysfunction in obesity", Physiol. Rev, 93, pp.1~21 (2013)
- Goossens, G. H., "Adipose tissue dysfunction and impaired metabolic health in human obesity : a matter of oxygen?", Front. Endocrinol, 6, pp.55~ (2015)
- Cifarelli, V., "Decreased adipose tissue oxygenation associates with insulin resistance in individuals with obesity", J. Clin. Investig, 130, pp.6688~6699 (2020)
- Ljungkvist, A. S., "Changes in tumor hypoxia measured with a double hypoxic marker technique", Int. J. Radiat. Oncol. Biol. Phys, 48, pp.1529~1538 (2000)
- Lee, Y. S., "Increased adipocyte O2 consumption triggers HIF-1α, causing inflammation and insulin resistance in obesity", Cell, 157, pp.1339~1352 (2014)
- Hewitson, K. S, "The HIF pathway as a therapeutic target", Drug Discov. Today, 9, pp.704~711 (2004)
- Duan, C., "Hypoxia-inducible factor 3 biology : complexities and emerging themes", Am. J. Physiol. Cell Physiol, 310, pp.C260~C269 (2016)
- Semenza, G. L, "O2-regulated gene expression : transcriptional control of cardiorespiratory physiology by HIF-1", J. Appl. Physiol, 96, pp.1173~1177 (2004)
- Hu, C. -J., "Differential roles of hypoxia-inducible factor 1α(HIF-1α)and HIF-2α in hypoxic gene regulation", Mol. Cell. Biol, 23, pp.9361~9374 (2003)
- 이지원, "Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions", Experimental and Molecular Medicine, 36(1), pp.1~12 (2004), 생화학분자생물학회
- Yang, S. L., "Progress on hypoxia-inducible factor-3 : Its structure, gene regulation and biological function", Mol. Med. Rep, 12, pp.2411~2416 (2015)
- Tolonen, J. -P., "A long hypoxia-inducible factor 3 isoform 2 is a transcription activator that regulates erythropoietin", Cell. Mol. Life Sci, 77, pp.3627~3642 (2020)
- Heikkilä, M., "Roles of the human hypoxia-inducible factor(HIF)-3α variants in the hypoxia response", Cell. Mol. Life Sci, 68, pp.3885~3901 (2011)
- Jiang, C., "Disruption of hypoxia-inducible factor 1 in adipocytes improves insulin sensitivity and decreases adiposity in high-fat diet–fed mice", Diabetes, 60, pp.2484~2495 (2011)
- Kihira, Y., "Deletion of hypoxia-inducible factor-1α in adipocytes enhances glucagon-like peptide-1 secretion and reduces adipose tissue inflammation", PLoS ONE, 9, pp.e93856~ (2014)
- Lee, K. Y., "The differential role of Hif1β", Arnt and the hypoxic response in adipose function, fibrosis, and inflammation, 2011, pp.14, 491~503
- Krishnan, J., "Dietary obesity-associated Hif1α activation in adipocytes restricts fatty acid oxidation and energy expenditure via suppression of the Sirt2-NAD+ system", Genes Dev, 26, pp.259~270 (2012)
- Halberg, N., "Hypoxia-inducible factor 1α induces fibrosis and insulin resistance in white adipose tissue", Mol. Cell. Biol, 29, pp.4467~4483 (2009)
- Zhang, X., "Adipose tissue-specific inhibition of hypoxia-inducible factor 1α induces obesity and glucose intolerance by impeding energy expenditure in mice", J. Biol. Chem, 285, pp.32869~32877 (2010)
- García-Martín, R., "Adipocyte-specific hypoxia-inducible factor 2α deficiency exacerbates obesity-induced brown adipose tissue dysfunction and metabolic dysregulation", Mol. Cell. Biol, 36, pp.376~393 (2016)
- Feng, Z., "Modulation of HIF-2α PAS-B domain contributes to physiological responses", Proc. Natl Acad. Sci. USA, 115, pp.E5990~E5999 (2018)
- Matsuura, H., "Prolyl hydroxylase domain protein 2 plays a critical role in diet-induced obesity and glucose intolerance", Circulation, 127, pp.2078~2087 (2013)
- Lin, Q., "Activation of hypoxia-inducible factor-2 in adipocytes results in pathological cardiac hypertrophy", J. Am. Heart Assoc, 2, pp.e000548~ (2013)
- 박찬수, "The Role of T Cells in Obesity-Associated Inflammation and Metabolic Disease", Immune Network, 22(1), pp.1~14 (2022), 대한면역학회[DOI]
- Lu, J., "Adipose tissue-resident immune cells in obesity and type 2 diabetes", Front. Immunol, 10, pp.1173~ (2019)
- Kim, D., "CXCL12 secreted from adipose tissue recruits macrophages and induces insulin resistance in mice", Diabetologia, 57, pp.1456~1465 (2014)
- Schmidt, A. M, "The semaphorin 3E", PlexinD1 axis regulates macrophage inflammation in obesity, 2013, pp.18, 461~462
- Yunna, C., "Macrophage M1", M2 polarization, 2020, pp.877, 173090~
- Morris, D. L., "Adipose tissue macrophages: phenotypic plasticity and diversity in lean and obese states", Curr. Opin. Clin. Nutr. Metab. Care, 14, pp.341~ (2011)
- Li, C., "Single-cell transcriptomics–based MacSpectrum reveals macrophage activation signatures in diseases", JCI Insight, 4, pp.e126453~ (2019)
- Suzuki, T., "ER stress protein CHOP mediates insulin resistance by modulating adipose tissue macrophage polarity", Cell Rep, 18, pp.2045~2057 (2017)
- Cinti, S., "Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans", J. Lipid Res, 46, pp.2347~2355 (2005)
- Takikawa, A., "HIF-1α in myeloid cells promotes adipose tissue remodeling toward insulin resistance", Diabetes, 65, pp.3649~3659 (2016)
- Sharma, M., "Enhanced glycolysis and HIF-1α activation in adipose tissue macrophages sustains local and systemic interleukin-1β production in obesity", Sci. Rep, 10, pp.1~12 (2020)
- Choe, S. S., "Macrophage HIF-2α ameliorates adipose tissue inflammation and insulin resistance in obesity", Diabetes, 63, pp.3359~3371 (2014)
- Poblete, J. M. S., "Macrophage HIF-1α mediates obesity-related adipose tissue dysfunction via interleukin-1 receptor-associated kinase M", Am. J. Physiol. Endocrinol. Metab, 318, pp.E689~E700 (2020)
- Wang, Q., "Cells in adipose tissue : critical players in immunometabolism", Front. Immunol, 9, pp.2509~ (2018)
- Tao, J. -H., "Hypoxia-inducible factors in T lymphocyte differentiation and function", Am. J. Physiol. Cell Physiol, 309, pp.C580~C589 (2015)
- Finlay, D. K., "PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells", J. Exp. Med, 209, pp.2441~2453 (2012)
- Shi, L. Z., "HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells", J. Exp. Med, 208, pp.1367~1376 (2011)
- O’Neill, A. F. M. A. L. A. J., "The role of HIF in immunity and inflammation", Cell Metab, 323, pp.524~536 (2020)
- McGettrick, A. F., "Obesity and vascular dysfunction", Pathophysiology, 15, pp.79~89 (2008)
- Claret, M., "Endothelial cells : new players in obesity and related metabolic disorders", Trends Endocrinol. Metab, 29, pp.781~794 (2018)
- Huang, Y., "Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy", Proc. Natl Acad. Sci. USA, 109, pp.17561~17566 (2012)
- Niecknig, H., "Role of reactive oxygen species in the regulation of HIF-1 by prolyl hydroxylase 2 under mild hypoxia", Free Radic. Res, 46, pp.705~717 (2012)
- Blouin, C. C., "Hypoxic gene activation by lipopolysaccharide in macrophages: implication of hypoxia-inducible factor 1α", Blood, 103, pp.1124~1130 (2004)
- Ziello, J. E., "Hypoxia-inducible factor(HIF)-1 regulatory pathway and its potential for therapeutic intervention in malignancy and ischemia", Yale J. Biol. Med, 80, pp.51~60 (2007)
- Herr, B., "The supernatant of apoptotic cells causes transcriptional activation of hypoxia-inducible factor–1α in macrophages via sphingosine-1-phosphate and transforming growth factor-β", Blood, J. Am. Soc. Hematol, 114, pp.2140~2148 (2009)
- Zhou, J., "Tumor necrosis factor-α causes accumulation of a ubiquitinated form of hypoxia inducible factor-1α through a nuclear factor-κB-dependent pathway", Mol. Biol. Cell, 14, pp.2216~2225 (2003)
- Hellwig-Bürgel, T., "Interleukin-1β and tumor necrosis factor-α stimulate DNA binding of hypoxia-inducible factor-1", Blood J. Am. Soc. Hematol, 94, pp.1561~1567 (1999)
- He, Q., "Regulation of HIF-1α activity in adipose tissue by obesity-associated factors : adipogenesis, insulin, and hypoxia", Am. J. Physiol. Endocrinol. Metab, 300, pp.E877~E885 (2011)
- Zheng, X., "Repression of hypoxia-inducible factor-1 contributes to increased mitochondrial reactive oxygen species production in diabetes", eLife, 11, pp.e70714~ (2022)
- Dodd, M. S., "Fatty acids prevent hypoxia-inducible factor-1α signaling through decreased succinate in diabetes", JACC Basic Transl. Sci, 3, pp.485~498 (2018)
- Bento, C., "Regulation of hypoxia-inducible factor 1 and the loss of the cellular response to hypoxia in diabetes", Diabetologia, 54, pp.1946~1956 (2011)
- Sun, K., "Selective inhibition of hypoxia-inducible factor 1α ameliorates adipose tissue dysfunction", Mol. Cell. Biol, 33, pp.904~917 (2013)
- Chin, C. -H., "YC-1 inhibits lipid droplet accumulation and induces lipolysis in lipid-laden RAW264.7 macrophages", J. Food Drug Anal, 19, pp.4~ (2011)
- Chin, C. -H., "YC-1, a potent antithrombotic agent, induces lipolysis through the PKA pathway in rat visceral fat cells", Eur. J. Pharmacol, 689, pp.1~7 (2012)
- Zhang, H., "Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth", Proc. Natl Acad. Sci. USA, 105, pp.19579~19586 (2008)
- Teijeiro, A., "Inhibition of the IL-17A axis in adipocytes suppresses diet-induced obesity and metabolic disorders in mice", Nat. Metab, 3, pp.496~512 (2021)
- Hu, M., "The role of berberine in the prevention of HIF-1α activation to alleviate adipose tissue fibrosis in high-fat-diet-induced obese mice", Evid. Based Complement. Alternat. Med, 2018, pp.12~ (2018)
- Shin, M. -K., "Metabolic consequences of high-fat diet are attenuated by suppression of HIF-1α", PLoS ONE, 7, pp.e46562~ (2012)
- Busiello, R. A., "Mitochondrial uncoupling proteins and energy metabolism", Front. Physiol, 6, pp.36~ (2015)
- Argyropoulos, G., "Invited review : uncoupling proteins and thermoregulation", J. Appl. Physiol, 92, pp.2187~2198 (2002)
- Valle, A., "Role of uncoupling proteins in cancer", Cancers, 2, pp.567~591 (2010)
- Machado, S. A., "Browning of the white adipose tissue regulation : new insights into nutritional and metabolic relevance in health and diseases", Nutr. Metab, 19, pp.1~27 (2022)
- Enerbäck, S., "Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese", Nature, 387, pp.90~94 (1997)
- Fleury, C., "Uncoupling protein-2 : a novel gene linked to obesity and hyperinsulinemia", Nat. Genet, 15, pp.269~272 (1997)
- Boss, O., "Uncoupling protein-3 : a new member of the mitochondrial carrier family with tissue-specific expression", FEBS Lett, 408, pp.39~42 (1997)
- Krauss, S., "The mitochondrial uncoupling-protein homologues", Nat. Rev. Mol. cell Biol, 6, pp.248~261 (2005)
- Arsenijevic, D., "Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production", Nat. Genet, 26, pp.435~439 (2000)
- Gong, D. -W., "Lack of obesity and normal response to fasting and thyroid hormone in mice lacking uncoupling protein-3", J. Biol. Chem, 275, pp.16251~16257 (2000)
- López-Soriano, F., "Amino acid and glucose uptake by rat brown adipose tissue. Effect of cold-exposure and acclimation", Biochem. J, 252, pp.843~849 (1988)
- Inokuma, K. -I., "Uncoupling protein 1 is necessary for norepinephrine-induced glucose utilization in brown adipose tissue", Diabetes, 54, pp.1385~1391 (2005)
- Giralt, M., "Mitochondrial uncoupling and the regulation of glucose homeostasis", Curr. Diabetes Rev, 13, pp.386~394 (2017)
- Kim, J. -w, "HIF-1-mediated expression of pyruvate dehydrogenase kinase : a metabolic switch required for cellular adaptation to hypoxia", Cell Metab, 3, pp.177~185 (2006)
- Han, J. S., "Adipocyte HIF2α functions as a thermostat via PKA Cα regulation in beige adipocytes", Nat. Commun, 13, pp.3268~ (2022)
- Basse, A. L., "Regulation of glycolysis in brown adipocytes by HIF-1α", Sci. Rep, 7, pp.1~15 (2017)
- Viengchareun, S., "Prolactin potentiates insulin-stimulated leptin expression and release from differentiated brown adipocytes", J. Mol. Endocrinol, 33, pp.679~691 (2004)
- Callapina, M., "Nitric oxide reverses desferrioxamine-and hypoxia-evoked HIF-1α accumulation—implications for prolyl hydroxylase activity and iron", Exp. cell Res, 306, pp.274~284 (2005)
- Yan, H. -F., "Deferoxamine ameliorates adipocyte dysfunction by modulating iron metabolism in ob", ob mice, 2018, pp.7, 604~
- Zhao, R. Z., "Mitochondrial electron transport chain, ROS generation and uncoupling", Int. J. Mol. Med, 44, pp.3~15 (2019)
- Mailloux, R. J., "Uncoupling proteins and the control of mitochondrial reactive oxygen species production", Free Radic. Biol. Med, 51, pp.1106~1115 (2011)
- Seo, J., "Fatty-acid-induced FABP5", HIF-1 reprograms lipid metabolism and enhances the proliferation of liver cancer cells, 2020, pp.3, 638~
- Safran, M., "Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity : assessment of an oral agent that stimulates erythropoietin production", Proc. Natl Acad. Sci. USA, 103, pp.105~110 (2006)
- Galmozzi, A., "ThermoMouse : an in vivo model to identify modulators of UCP1 expression in brown adipose tissue", Cell Rep, 9, pp.1584~1593 (2014)
- Wang, H., "A dual Ucp1 reporter mouse model for imaging and quantitation of brown and brite fat recruitment", Mol. Metab, 20, pp.14~27 (2019)
- Loomis, W. F, "Reversible inhibition of the coupling between phosphorylation and oxidation", J. Biol. Chem, 173, pp.807~ (1948)
- Colman, E., "Dinitrophenol and obesity : an early twentieth-century regulatory dilemma", Regul. Toxicol. Pharmacol, 48, pp.115~117 (2007)
- Cavalieri, R., "Activating ligands of Uncoupling protein 1 identified by rapid membrane protein thermostability shift analysis", Mol. Metab, 62, pp.101526~ (2022)
- Rial, E., "Retinoids activate proton transport by the uncoupling proteins UCP1 and UCP2", EMBO J, 18, pp.5827~5833 (1999)
- Wells, C., "The cJun kinase inhibitor SP600125 stimulates expression of PPARγ co-activator 1α (PGC-1α) and uncoupling protein 1 (UCP1) in the HIB-1B brown fat preadipocyte cell line", Proc. Nutr. Soc, 67, pp.E393~ (2008)
